Challenges of Zr89 Imaging

While PET imaging with radionuclides such as F18 and Ga68 have proven to provide high quality diagnostic imaging, imaging with other radionuclides can be more challenging. Zr-89 is one such radionuclide. Although Zr-89 has advantageous labelling properties for cell imaging and the imaging of monoclonal antibodies, the radionuclide is non-ideal imaging qualities mostly due to its low dosage, and also brings with it radiation safety challenges. This webinar will present both sides of Zr-89 imaging, the clinically relevant opportunities for the radionuclide, and the quantification challenges, handling and the safety aspects of Zr-89.

Learning Objectives: The aim of this webinar is to show the potential and the challenges of Zr-89 imaging.